All the assets are tied - patents includedhttps://www.bioexx.com/article/bioexx-refinance-debt-increased-loan-facility
TORONTO, ONTARIO – June 7, 2012 –
"Romspen will have a first secured interest in the Company’s Saskatoon plant and a general security agreement covering the balance of the Company’s assets"
The Romspen loan is a one-year term debt facility, with interest accruing at 12% during the term, and the principal amount and accrued interest due at maturity. Romspen has also been granted 10,000,000 share purchase warrants with a term of 5 years and an exercise price equal to $0.088, based on the 10-day volume weighted average trading price of the Company’s common shares as at June 5, 2012. Closing of the loan facility is subject to customary conditions on similar transactions and is expected to occur on or about June 19, 2012.
“We remain on course in the execution of our strategy, and are pleased to be bolstering our cash position to provide greater strength and flexibility as we move forward through scale-up engineering and our strategic partner process,” said BioExx CEO, Chris Schnarr.
In June 2012 CS said there would be news of a JV by Q3 2012 then Q4 2012 by Q12013 by Q2 2013
you'all just wait for news by Christmas 2012 by summer 2013 next is fall 2013 then christmas 2013
the $ 5,000 weekly cheque keeps a coming and the pied piper leads the lemmings to the the cliff